Retinoid acids (RA), also known as ATRA, interact with retinoic acid receptors (RAR) inducing growth inhibition together with differentiation in many cell types and are seen as promising candidate agents for the prevention and treatment of several human cancers. The gene discussed is RARA; the disease is cancer.